Camber Pharmaceuticals introduces eletriptan hydrobromide tablets, which are indicated for the acute treatment of migraine, with or without aura, in adult patients. The tablets are available in two dosage strengths, 20 mg and 40 mg, both sold in packs of six unit-dose tablets.